.jpeg)
Bosutinib drug name
Bosutinib (Bosutinib) belongs to the second-generation tyrosine kinase inhibitor (TKI) class. It is mainly used to treat patients with chronic myeloid leukemia (CML), especially those who have failed or developed resistance to previous treatments. Its chemical name is 4-methyl-N-(3-(4-methylpiperidin-1-yl)propionyl)anilide. In addition to the common name of bosutinib, it also has other names, such as bosutinib, bosutinib, posutinib, etc. These names all refer to the same drug, just expressed in slightly different ways. Bosutinib is sold as Bosulif, which is the brand name it is marketed under. Patients should use it under the guidance of a doctor to ensure the safety and effectiveness of the drug.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
